Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256)

Ask supplier a question | View on supplier's website

Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) is a fully humanized IgG2κ monoclonal antibody that targets the B-cell growth factor APRIL (TNFSF13), with the potential to treat IgA nephropathy (IgAN). MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2317
Sku #	A2317-1mg*25
Pricing	1mg*25, $2370.00

Feedback